Levin Capital Strategies’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,338
Closed -$58.3K 287
2024
Q1
$58.3K Sell
1,338
-625
-32% -$25.9K 0.01% 225
2023
Q4
$80.1K Buy
1,963
+1,588
+423% +$86.3K 0.01% 234
2023
Q3
$31.1K Sell
375
-125
-25% -$11.3K ﹤0.01% 261
2023
Q2
$47.6K Sell
500
-750
-60% -$96.2K 0.01% 260
2023
Q1
$173K Sell
1,250
-1,500
-55% -$137K 0.02% 200
2022
Q4
$197K Buy
2,750
+1,950
+244% +$184K 0.03% 188
2022
Q3
$94K Buy
800
+550
+220% +$98K 0.01% 205
2022
Q2
$46K Sell
250
-500
-67% -$90.8K 0.01% 244
2022
Q1
$176K Buy
+750
New +$151K 0.02% 257
2021
Q3
Sell
-238
Closed -$175K 409
2021
Q2
$238K Buy
+238
New +$237K 0.02% 261
2021
Q1
Sell
-250
Closed -$235K 408
2020
Q4
$235K Buy
+250
New +$134K 0.03% 235

Other funds holding DNMR

Levin Capital Strategies's DNMR Position: Q2 2024 in Review

Levin Capital Strategies sold out of Danimer Scientific, Inc. (DNMR) in Q2 2024, closing a stake of 1,338 shares — an estimated $58.3K sold.

Levin Capital Strategies first reported a position in DNMR in Q4 2020 and held it in 11 quarters. The position peaked at $238K in Q2 2021. 139 funds tracked by Wall St. Rank hold DNMR as of Q2 2024.

  • Levin Capital Strategies reported no remaining Danimer Scientific, Inc. position as of Q2 2024 after selling out during the quarter.
  • Levin Capital Strategies sold 1,338 Danimer Scientific, Inc. shares in Q2 2024, an estimated $58.3K.
  • Levin Capital Strategies first reported a position in Danimer Scientific, Inc. in Q4 2020 and held it in 11 quarters.
  • Levin Capital Strategies's Danimer Scientific, Inc. position peaked at $238K in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q2 2024.

Based on Levin Capital Strategies's 13F filing for Q2 2024, filed 7 Aug 2024.